These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16980216

  • 1. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
    Veale DJ, Fearon U.
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
    [Abstract] [Full Text] [Related]

  • 2. Angiogenesis--a new target for future therapy.
    Pandya NM, Dhalla NS, Santani DD.
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [Abstract] [Full Text] [Related]

  • 3. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis.
    Schoettler N, Brahn E.
    Curr Opin Investig Drugs; 2009 May; 10(5):425-33. PubMed ID: 19431075
    [Abstract] [Full Text] [Related]

  • 4. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ.
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [Abstract] [Full Text] [Related]

  • 5. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F, Das B.
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [Abstract] [Full Text] [Related]

  • 6. [The role of angiogenesis in rheumatoid arthritis].
    Pałgan K.
    Postepy Hig Med Dosw; 2000 Nov; 54(6):855-65. PubMed ID: 11227381
    [Abstract] [Full Text] [Related]

  • 7. Anti-angiogenic function of tocotrienol.
    Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.
    Asia Pac J Clin Nutr; 2008 Nov; 17 Suppl 1():253-6. PubMed ID: 18296349
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
    Vizán P, Sánchez-Tena S, Alcarraz-Vizán G, Soler M, Messeguer R, Pujol MD, Lee WN, Cascante M.
    Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

  • 13. [Targeting angiogenesis in oncology].
    Fayette J, Soria JC, Armand JP.
    Pathol Biol (Paris); 2006 May 01; 54(4):199-205. PubMed ID: 16753494
    [Abstract] [Full Text] [Related]

  • 14. Angiogenesis: a therapeutic target in arthritis.
    Walsh DA, Haywood L.
    Curr Opin Investig Drugs; 2001 Aug 01; 2(8):1054-63. PubMed ID: 11892913
    [Abstract] [Full Text] [Related]

  • 15. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.
    Hashimoto A, Tarner IH, Bohle RM, Gaumann A, Manetti M, Distler O, Steinmeyer J, Ulfgren AK, Schulz A, Gay S, Müller-Ladner U, Neumann E.
    Arthritis Rheum; 2007 Apr 01; 56(4):1094-105. PubMed ID: 17393418
    [Abstract] [Full Text] [Related]

  • 16. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice.
    del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M, Pablos JL.
    Arthritis Rheum; 2009 Oct 01; 60(10):2926-34. PubMed ID: 19790065
    [Abstract] [Full Text] [Related]

  • 17. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 01; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 18. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z, Koch AE.
    Curr Opin Rheumatol; 2007 May 01; 19(3):289-95. PubMed ID: 17414958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.